Invesco Ltd. Anika Therapeutics, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 26,158 shares of ANIK stock, worth $451,748. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,158

Previous 37,321 29.91%

Holding current value

$451,748

Previous $947,000 30.1%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$24.57 - $28.47 $274,274 - $317,810	-11,163 Reduced 29.91%	26,158 $662,000
Q1 2024 May 14, 2024	BUY	$21.95 - $26.42 $316,365 - $380,791	14,413 Added 62.92%	37,321 $947,000
Q4 2023 Feb 12, 2024	SELL	$18.47 - $23.3 $155,406 - $196,046	-8,414 Reduced 26.86%	22,908 $519,000
Q3 2023 Nov 13, 2023	SELL	$16.98 - $26.1 $823,037 - $1.27 Million	-48,471 Reduced 60.75%	31,322 $583,000
Q2 2023 Aug 11, 2023	BUY	$25.16 - $28.86 $38,067 - $43,665	1,513 Added 1.93%	79,793 $2.07 Million
Q1 2023 May 12, 2023	SELL	$25.91 - $32.1 $414,974 - $514,113	-16,016 Reduced 16.98%	78,280 $2.25 Million
Q4 2022 Feb 13, 2023	BUY	$23.85 - $31.91 $235,304 - $314,824	9,866 Added 11.69%	94,296 $2.79 Million
Q3 2022 Nov 14, 2022	SELL	$21.74 - $24.68 $33,544 - $38,081	-1,543 Reduced 1.79%	84,430 $2.01 Million
Q2 2022 Aug 15, 2022	BUY	$20.4 - $25.53 $8,608 - $10,773	422 Added 0.49%	85,973 $1.92 Million
Q1 2022 May 16, 2022	SELL	$24.7 - $36.54 $14,449 - $21,375	-585 Reduced 0.68%	85,551 $2.15 Million
Q4 2021 Feb 14, 2022	SELL	$35.83 - $45.03 $131,173 - $164,854	-3,661 Reduced 4.08%	86,136 $3.09 Million
Q3 2021 Nov 15, 2021	SELL	$38.75 - $44.47 $219,596 - $252,011	-5,667 Reduced 5.94%	89,797 $3.82 Million
Q2 2021 Aug 17, 2021	SELL	$39.42 - $48.08 $122,123 - $148,951	-3,098 Reduced 3.14%	95,464 $4.13 Million
Q1 2021 May 17, 2021	BUY	$32.49 - $45.96 $164,236 - $232,327	5,055 Added 5.41%	98,562 $4.02 Million
Q4 2020 Feb 16, 2021	SELL	$32.59 - $45.26 $347,311 - $482,335	-10,657 Reduced 10.23%	93,507 $4.23 Million
Q3 2020 Nov 16, 2020	SELL	$32.56 - $38.57 $595,652 - $705,599	-18,294 Reduced 14.94%	104,164 $3.69 Million
Q2 2020 Aug 14, 2020	SELL	$27.83 - $37.73 $73,582 - $99,758	-2,644 Reduced 2.11%	122,458 $4.62 Million
Q1 2020 May 15, 2020	SELL	$22.38 - $54.06 $146,253 - $353,282	-6,535 Reduced 4.96%	125,102 $3.62 Million
Q4 2019 Feb 14, 2020	SELL	$51.85 - $73.36 $46,302 - $65,510	-893 Reduced 0.67%	131,637 $6.83 Million
Q3 2019 Nov 14, 2019	BUY	$40.05 - $57.47 $1.18 Million - $1.69 Million	29,431 Added 28.55%	132,530 $7.27 Million
Q2 2019 Aug 14, 2019	SELL	$30.3 - $41.14 $1.08 Million - $1.47 Million	-35,777 Reduced 25.76%	103,099 $4.19 Million
Q1 2019 May 15, 2019	SELL	$29.37 - $40.49 $534,387 - $736,715	-18,195 Reduced 11.58%	138,876 $4.2 Million
Q4 2018 Feb 14, 2019	BUY	$30.16 - $43.0 $4.74 Million - $6.75 Million	157,071 New	157,071 $5.28 Million

Others Institutions Holding ANIK

# of Institutions

121

Shares Held

11.8M

Call Options Held

2.7K

Put Options Held

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $252M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account